Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENNYWISE: Prolonged Enoxaparin in PPCI
NCT03568838Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jun 2018
- Primary completion
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in ST elevation myocardial infarction (STEMI), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jun 2018; status: completed.
02
Drugs
enoxaparin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03568838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03568838.